Today

Agents

Chat

Arena

Discover

More

App

Trinity Biotech regains Nasdaq minimum bid price compliance - TRIB News | Rallies

Trinity Biotech regains Nasdaq minimum bid price compliance

TRIB•2026-08-14

Nasdaq compliance regained

Trinity Biotech regained compliance with Nasdaq’s $1 minimum bid price rule following 10 consecutive business days above $1.

Nasdaq confirmed compliance on Aug. 7, 2026, covering the period from July 24, 2026 through Aug. 6, 2026.

Related News

Aveanna Healthcare Holdings Inc <AVAH.O>: UBS raises target price to $13 from $8

AVAH•2026-08-14

Applied Materials Inc <AMAT.O>: UBS Cuts Target Price to $675 From $705

AMAT•2026-08-14

Schrödinger Inc <SDGR.O>: UBS Raises Target Price To $19 From $13

•

2026-08-14

Canton Strategic reports first operating revenue in Q2

CNTN•2026-08-14

Algorhythm Holdings Q2 revenue jumps on expanded contract

RIME•2026-08-14